PADI4 and acute promyelocytic leukemia: Importantly, unlike first-generation PAD4 inhibitors that induce feedback upregulation of PAD4 in APL cells, Western blot analysis confirmed that YW3-56 reduced PAD4 protein level in a dose-dependent manner, with the most pronounced suppression observed at higher concentrations, consistent with our previous findings (Figure 1E) [24].